Table 4.
Univariable | Multivariable | |||||
---|---|---|---|---|---|---|
OR | 95% CI | p value | OR | 95% CI | p value | |
Frailty | ||||||
No frailty | Ref | Ref | ||||
Low frailty | 7.14 | 3.01–16.9 | < 0.001 | 1.44 | 0.51–4.10 | 0.494 |
Intermediate frailty | 34.5 | 14.6–81.9 | < 0.001 | 4.69 | 1.37–16.0 | 0.014 |
High frailty | 133.1 | 51.4–345.1 | < 0.001 | 12.2 | 2.67–55.5 | 0.001 |
Age ≥ 65 years | 5.20 | 3.40–7.96 | < 0.001 | 2.24 | 0.62–8.07 | 0.217 |
Male (vs female) | 1.59 | 1.07–2.37 | 0.020 | 0.77 | 0.26–2.33 | 0.647 |
BMI ≥ 30 | 0.70 | 0.46–1.06 | 0.091 | – | ||
White (vs others) | 1.06 | 0.71–1.56 | 0.790 | – | ||
ASA ≥ 3, n (%) | 29.4 | 11.9–72.4 | < 0.001 | 6.04 | 0.99–36.89 | 0.052 |
Albumin ≤ 3.5 g/dl, n (%) | 7.15 | 4.09–12.51 | < 0.001 | 1.43 | 0.38–5.38 | 0.594 |
Total bilirubin ≥ 1.2 mg/dl, n (%) | 3.88 | 2.58–5.85 | < 0.001 | 1.73 | 0.57–5.22 | 0.330 |
SGOT ≥ 40 U/L | 2.81 | 1.87–4.25 | < 0.001 | 1.98 | 0.65–6.01 | 0.228 |
Creatinine ≥ 1.2, n (%) | 5.46 | 3.65–8.17 | < 0.001 | 1.26 | 0.38–4.19 | 0.712 |
Platelet ≤ 150, n (%) | 4.03 | 2.62–6.22 | < 0.001 | 1.03 | 0.27–3.88 | 0.966 |
Hematocrit ≤ 35, n (%) | 5.30 | 3.47–8.10 | < 0.001 | 1.44 | 0.38–5.50 | 0.591 |
White blood cell ≥ 11 | 1.71 | 1.15–2.55 | 0.008 | 1.99 | 0.68–5.81 | 0.209 |
No frailty = mFI 0, Low frailty = mFI 1–2, Intermediate frailty = mFI 3–4, High frailty = mFI ≥ 5
BMI body mass index, ASA American Society of Anesthesiologists, SGOT, serum glutamic-oxaloacetic transaminase; italic font represents statistically significant associations